SCHEMBL6785377

SCHEMBL6785377

COc1cccc(-c2ccc3[nH]c4cnn(C)c4c(=O)c3c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.47
WDR77 Q9BQA1 1/20 0.47
ABCG2 Q9UNQ0 1/20 0.45
BRD4 O60885 1/20 0.44
JAK2 O60674 1/20 0.44
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41
TUBA3C P0DPH7 1/20 0.41
TUBA1B P68363 1/20 0.41
TUBA4A P68366 1/20 0.41
TUBB4B P68371 1/20 0.41
TUBB3 Q13509 1/20 0.41
TUBB2A Q13885 1/20 0.41
TUBB8 Q3ZCM7 1/20 0.41
TUBA3E Q6PEY2 1/20 0.41
TUBA1A Q71U36 1/20 0.41
TUBA1C Q9BQE3 1/20 0.41
TUBB6 Q9BUF5 1/20 0.41
TUBB2B Q9BVA1 1/20 0.41
TUBB1 Q9H4B7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14255815 0.87 ABCG2 (0.56) ABCG2KDM4EALDH1A1GAAHPGD
SCHEMBL6782703 0.84 KIF11 (0.43) GAAPIM1CHEK1WEE1
SCHEMBL6782106 0.84 ABCG2 (0.43) PRMT5WDR77ABCG2KDM4EALDH1A1
SCHEMBL6784780 0.81 PRMT5 (0.44) PRMT5WDR77BRD4ALDH1A1GAA
SCHEMBL6785560 0.77 ABCG2 (0.42) PRMT5WDR77ABCG2KDM4EALDH1A1
SCHEMBL13308543 0.77 ALDH1A1 (0.63) ABCG2PGRKDM4EALDH1A1GLA
SCHEMBL6781520 0.75 MEN1 (0.53) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL6786900 0.74 KDM4E (0.51) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL6788209 0.74 PARP1 (0.42) PRMT5WDR77KDM4EALDH1A1GLA
SCHEMBL6787339 0.72 KDM4E (0.48) ABCG2TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed
EP-1310498-A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PFIZER INC. (US) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG PRMT5 612/4885WDR77 535/4885ABCG2 1646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.